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ABSTRACT  
 
NYO YAMONN 
Examination of the association between patient empowerment and diabetes management among 
an urban African American population by gender, age, socioeconomic status and education level 
(Under the direction of FRANCES McCARTY, Ph.D., FACULTY MEMBER) 
 
 
 Diabetes mellitus is a significant problem in the United States with the burden being greater in 
the African American population. Because diabetes is complex and costly, the importance of 
self-care management changes the disease management paradigm from “provider-centered” to 
“patient-centered”. Empowerment is recommended as a possible solution for barriers to self-
management education and better diabetes care. “Patient empowerment is defined as helping 
patients discover and develop the inherent capacity to be responsible for one’s own life.” 
Although patient empowerment is a valuable philosophy, there are gaps between the philosophy 
and actual practice. There are limited studies addressing the effectiveness of patient 
empowerment at improving diabetes management. Therefore, this study examined the 
association of patient empowerment and diabetes management by gender, age, socioeconomic 
status and education level by using the data from the Patient Empowerment to Improve Diabetes 
Care (PEIDiC) intervention conducted in the Diabetes Clinic of the Grady Health System (GHS). 
In this study, diabetes management was measured by glycated hemoglobin (HbA1c) level which 
shows the average blood glucose level over the past two to three months. Patient empowerment 
was measured by two standardized tools which were the Diabetes Empowerment Scale-Short 
Form (DES-SF) and Patient Activation Measure (PAM). In this study, patient empowerment 
scores measured by these tools were not associated with HbA1c level in African American 
diabetes patients of the Diabetes Clinic of the GHS. Further study is necessary to understand the 
association between patient empowerment and diabetes disease management by using different 
measures of patient empowerment, different levels of disease management, and measurement in 
different settings. 
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Chapter I 
Introduction 
 
According to the Centers for Disease Control and Prevention (CDC), 23.6 million people 
living in the United States—7.8% of the total population—is estimated to be suffering from diabetes 
mellitus. Among them, 75% are diagnosed and 25% do not know their diabetic health status (CDC, 
2009).  
“Diabetes is a disease in which the body has a shortage of insulin or a decreased ability to use 
insulin, a hormone that allows glucose (sugar) to enter cells and be converted to energy. When 
diabetes is not controlled, glucose and fats remain in the blood and, over time, damage vital organs” 
(CDC, 2009). There are two major types of diabetes: type 1 and type 2 diabetes. Type 1 diabetes 
develops when the body’s immune system destroys pancreatic beta cells which make the insulin 
hormone that regulates blood glucose in the body (CDC, 2007). This form of diabetes mainly occurs 
in children and young adults but it can actually occur at any age.  Type 1 diabetes accounts for 5 to 
10% of all diagnosed diabetes cases and type 2 diabetes accounts for 90 to 95% of all diagnosed 
diabetes cases. Although there is no known way to prevent type 1 diabetes, type 2 diabetes can be 
prevented or its onset delayed up to a certain extent (CDC, 2007).  
Type 2 diabetes usually develops when the need for insulin rises and the pancreas gradually 
loses its ability to produce it (CDC, 2007).  Type 2 diabetes is usually associated with older age, 
obesity, a history of gestational diabetes, impaired glucose metabolism, physical inactivity, and race 
or ethnicity. Hispanic or Latino Americans, American Indians, and some Asian Americans and 
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Native Hawaiians or Other Pacific Islanders are at particularly high risk for type 2 diabetes (CDC, 
2007).
Almost 12% of those diagnosed with diabetes are African Americans and 3.7 million or 
14.7% of all non-Hispanic blacks age 20 and older were estimated to have diabetes (National 
Institute of Health, 2008). African Americans were twice as likely to be diagnosed with diabetes as 
non-Hispanic Whites. According to 2006 data, African American men were 2.2 times as likely to 
start treatment for end-stage renal disease related to diabetes, as compared to non-Hispanic white 
men. African Americans were 2.3 times as likely as non-Hispanic Whites to die from diabetes. 
According to 2005 data, diabetic African Americans have twice the chance of being hospitalized 
compared to diabetic non-Hispanic Whites (U.S Department of Health and Human Services, 2009). 
In Georgia, the rate of diabetes is even higher than the national rate. In 2007, 10.1% of 
Georgia adult population had been diagnosed with diabetes.  It is estimated that for every two people 
who have been diagnosed with diabetes, another has not yet been diagnosed, and therefore, the actual 
rate is estimated to be doubled which would be 20.2% (Georgia Department of Community Health, 
Division of Public Health, 2008).   
Diabetes was the seventh highest cause of death listed on U.S. death certificates in 2006 in 
the U.S. as well as in Georgia. In Georgia, the age-adjusted death rate per 100,000 populations was 
2.3 times higher among the African American population than among Whites and it is identical to the 
national estimation (Georgia Department of Community Health, Division of Public Health, 2008). 
These data indicate the size of the burden of diabetes and its complications in the African American 
population in Georgia.  
In addition, the cost of diabetes is very high. The total health care cost for diabetes is 
estimated to be $174 billion, which includes direct medical costs of $116 billion and indirect costs of 
$58 billion (The American Diabetes Association (ADA), 2008). Indirect medical costs are related to 
disability, work loss and premature death. It is estimated that 1 in every 5 health care dollars in the 
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U.S. is spent caring for someone with diagnosed diabetes, while 1 in every 10 health care dollars is  
attributed to diabetes (ADA, 2008). These estimations do not include social cost of intangibles such 
as pain and suffering, care provided by non paid caregivers, excess medical cost associated with 
undiagnosed diabetes, and diabetes-attributed costs for health care expenditure categories. Therefore, 
the actual national burden of diabetes is likely to be higher than the $174 billion estimation (ADA, 
2008).  
Moreover, people with diagnosed diabetes have medical expenditures that are about 2.3 times 
higher than medical expenditures for people without diabetes (CDC, 2009). Diabetes related 
complications account for nearly 50% of direct health care or medical cost due to diabetes (ADA, 
2008). Secondary and tertiary prevention methods that is, effective management to prevent 
complications related to diabetes and reduced morbidity and mortality related to complications of 
diabetes, can play a very important role in reducing diabetes related health care costs. 
 
Purpose of Study 
 The purpose of this study is aimed at understanding the factors which may improve diabetes 
disease management. Understanding the factors that influence diabetes management will provide 
significant information regarding areas in which diabetes disease management can be improved. In 
diabetes disease management, the importance of patient empowerment has been recognized and the 
paradigm is shifting from a traditional provider-centered model to a patient-centered model (Funnell 
& Anderson, 2004; Funell et al., 1991). “Patient empowerment is defined as helping patients 
discover and develop the inherent capacity to be responsible for one’s own life” (Funnell & 
Anderson, 2004, p.124; Funnell et al., 1991). There are many inherent issues, such as gaps between 
the theoretical concept and practical application of patient empowerment in diabetes care and its 
short-term and long-term effects in diabetes management. It is important that the total effects of the 
patient empowerment approach to diabetes management are better understood. This study looks at 
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the association between patient empowerment and glycated hemoglobin (HbA1c) level.  HbA1c test 
is one of the recommended tests for diagnosis and it is also used to predict the risk for the long-term 
complications of diabetes (ADA, 2010a; ADA, 2010b). It gives the average blood glucose level of a 
person over the past two to three months and the measure is given as a percentage (ADA, 2010a). 
Specifically, this study is focused on whether or not there is an association between patient 
empowerment and diabetes management in terms of HbA1c by age, socioeconomic status, education 
and gender. 
 
Hypothesis 
Based on the aforementioned research question, the following hypotheses were created: 
1. H0 = DES score in diabetes care is not negatively associated with the HbA1C level of diabetes 
patient  
Ha = Diabetes Empowerment Scores (DES score) in diabetes care is negatively associated with the 
HbA1c level of diabetes patient 
2. H0= PAM score is not negatively associated with the HbA1c level of diabetes patient  
Ha= Patient Activation Measure score (PAM score) in diabetes care is negatively associated with the 
HbA1c level of diabetes patient 
 
 
 
 
 
 
 5 
Chapter II 
Literature Review 
 
 Currently in the United States, nearly 8% of population is living with diabetes mellitus (CDC, 
2009). Moreover, diabetes is a serious disease and it can lead to severe complications, such as 
blindness, kidney damage, cardiovascular disease, stroke, and lower-limb amputations. To date, no 
cure for diabetes has been found. However, once a person has diabetes there are ways to manage it 
(CDC 2007).  
 Diabetes is the leading cause of new cases of blindness among adults aged 20-74 years old,   
kidney failure and non-traumatic lower extremities amputation (CDC 2007). Therefore, it is 
imperative for the people living with diabetes to learn how to correctly manage the disease in order to 
prevent these complications and maintain their quality of life.  For both type 1 and type 2 diabetes, 
the best prophylaxis against microvascular complications is tight glycemic control. The best 
prophylaxis against macrovascular complications is comprehensive risk reduction including 
glycemic, lipid and blood pressure control, smoking cessation, regular eye and feet examinations and 
other regular care according to the recommendations of the American Diabetes Association (ADA) 
(ADA, 2010b; CDC 2007; Stratton, et al., 2000).  
 In general, every percentage point drop in HbA1c blood levels can reduce the risk of micro 
vascular complications such as eye, kidney and nerve diseases by 40% (CDC, 2007). Blood pressure 
control for patients with diabetes reduces the risk of cardiovascular disease such as heart disease or 
stroke among the persons with diabetes by 33% to 50%. In most cases, for every 10 mmHg reduction 
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in systolic blood pressure, the risk for any complication related to diabetes is reduced by 12% (CDC, 
2007).  
 Improved control of low density lipoprotein cholesterol can reduce cardiovascular 
complications by 20-50% for patient with diabetes. Detection and treating diabetes eye disease with 
laser therapy can reduce the development of severe vision loss by about 50 - 60%. Comprehensive 
foot care programs can reduce amputation rates by 45-85%. Detecting and treating early diabetes 
kidney disease by lowering blood pressure can reduce the decline in kidney function by 30-70% 
(CDC, 2007).  
 Glycemic control is a fundamental requirement for day-to-day management of diabetes.  It is 
also the most important factor in care and prevention (ADA, 2005; Stratton, et al., 2000). Glycemic 
control is measured by different types of blood glucose level measurement such as fasting blood 
glucose, random blood glucose level, two hour postprandial blood glucose level and HbA1c level 
(ADA, 2005).  
 Fasting glucose is the standard measure used to diagnose diabetes in the United States. 
Currently, HbA1c test is also recommended for diagnostic purpose as well as prediction of the risk 
for the long-term complications of diabetes (ADA, 2010a; ADA, 2010b). It gives the average blood 
glucose level of a person over the past two to three months and its measure is given as a percentage 
(ADA, 2010a). The recommended testing frequency of HbA1c is approximately every three months 
but it can be more or less frequent depending on the stability of glycemic control (ADA, 2010b).  
 Selvin et al. (2010) said HbA1c test have certain advantages over fasting glucose test for the 
diagnosis of diabetes. In their study, HbA1c levels were found to be an accurate predictor of future 
diabetes and a better predictor for diabetes related complications such as stroke and heart disease 
(Selvin et al., 2010). HbA1c tests have an advantage over the fasting blood glucose because they do 
not require patients to fast for accurate results; they have stability as they are not affected by stress, 
illness and, day-to-day variability (ADA, 2010a).  
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 In January 2010, the ADA revised their recommendation for the screening and diagnosis of 
diabetes. In the revised guidelines, the ADA classified people with HbA1c levels 5.7 to 6.4 percent 
as very high risk for developing diabetes over the following five years (ADA, 2010b).  A person 
without diabetes would have an HbA1c of about five percent and the diagnosis of diabetes would be 
made if the level rose to 6.5 percent or higher (ADA, 2010b). The ADA recommends people with 
diabetes to keep HbA1c level below seven percent in order to manage their disease properly and 
prevent complications (ADA, 2010b).  
 Although people with type 1 diabetes need insulin delivered by an injection or a pump for 
their survival, people with type 2 diabetes may be able to control their glucose level just by following 
an exercise program and a healthy meal plan (CDC, 2007). Among adults with diagnosed diabetes in 
both type 1 or type 2, 14% take insulin only, 13% take both insulin and oral medication, 57% take 
oral medication only and, 16% do not take either insulin or oral medication. Medications for each 
individual with diabetes usually change during the course of the disease (CDC, 2007).  
 Because of its long-term nature and importance of day to day care, diabetes self-care 
management and active participation of patients in their care are important factors in successful 
diabetes management (Funnell et al., 2010). Although good practices of physicians and other health 
care providers are important, disease management is not solely in the hands of health care providers. 
Moreover, many psychological, emotional, social, spiritual, cognitive, economic, literacy, and 
cultural factors are intertwined with diabetes management, and traditional medical models usually 
ignore these important factors (B. Anderson & Funnell, 2005; Funnell & Anderson, 2004). 
Therefore, Funnell et al. (1991) proposed the empowerment model as an appropriate model for 
diabetes management to address the areas neglected in traditional medical models in diabetes care 
(Funnell & Anderson, 2004; Funnell et al., 1991).  
 In this literature review, the empowerment model in diabetes care will be discussed by its 
important components. They are six components to this model; (1) racial and cultural issue, (2) the 
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concept of patient empowerment in the diabetes care, (3) self-management education, (4) goal 
setting, (5) patient-provider communication, and (6) literacy. 
 
(1) Racial & Cultural Issue 
 Racial or ethnic minority populations and people with low socioeconomic status are facing a 
greater risk of developing diabetes complications (Liburd, 2010). As stated, the African American 
population is one of the populations who are having a higher burden of diabetes both in terms of 
prevalence and complications. Correa-de-Araujo, McDermott, & Moy (2006) found that 
hospitalization due to diabetes complications decrease with higher income level in each racial and 
ethnic group (Correa-de-Araujo et al., 2006). Therefore, income appears to be a very important factor 
in diabetes management and control.  
 However, disparities in quality of health care, differences in health care behavior such as 
nutritional habits or physical inactivity, adherence to medication, psychosocial factors such as 
differing level of trust in providers or the health care systems, health literacy, educational attainment, 
access to health care, lack of or inadequate health insurance are also possible factors in the disparities 
of diabetes control (Dreeben, 2001; Liburd, 2010).    
 “Research has shown that doctors have poorer communication with minority patients than 
with others, but problems in doctor-patient communication have received little attention as a 
potential cause, a remedial one, of health disparities” (Ashton, et al., 2003). Cultural competency and 
cultural sensitivity of health care provider is a necessity to address health disparities in the different 
racial and ethnic groups. The patient empowerment approach is one of the possible solutions for 
addressing racial disparity in diabetes care (Dreeben, 2001; Greene, McClellan, Gardner & Larson, 
2006; Liburd, 2010, p. 45). 
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(2) The Concept of Patient Empowerment in Diabetes Care 
 Patient empowerment is a philosophy that requires “a paradigm shift” from the traditional 
provider-centered medical model to a patient-centered collaborative care (Funnell & Anderson, 2004; 
Funnell & Anderson, 2003; Funnell et al., 1991). “Patient empowerment is defined as helping 
patients discover and develop the inherent capacity to be responsible for one’s own life” (Funnell & 
Anderson, 2004, p.124; Funnell et al., 1991).  
 To foster the philosophy of empowerment in their practice, the health care providers need to 
recognize that people with diabetes are the experts of their own lives and are responsible for choices 
they make (Funnell & Anderson, 2003). Within this model, the role of the health care providers is “to 
inspire, inform, support and facilitate their patients to identify and attain their own goals” (Funnell & 
Anderson, 2003, p.456). Instead of applying behavior strategies to patients to change behavior, the 
health care providers should explain these strategies to their patients and allow them to make changes 
in behaviors of their own choosing (Funnell & Anderson, 2003; Funnell et al, 1991; Anderson, 
Funnell, Barr, Dedrick, & Davis, 1991). Because these changes are identified by the patients as being 
important to them, they are more likely to maintain the changes (Anderson et al., 1991; Funnell & 
Anderson, 2003; Funnell et al, 1991).    
 In the empowered caring model, which evolved out of a qualitative explanatory study with 
public health nurses, these nurses conceptualized empowerment as “an active, internal process of 
growth that was rooted in one’s own cultural or religious or personal belief systems, reached toward 
actualizing one’s full potential, and occurred within the context of a nurturing nurse-client 
relationship” (Falk-Rafael, 2001, p.4, Appendix A). The public health nurses believed that providers 
could only facilitate empowerment in others and could not create it for them. They identified that the 
empowerment process included active participation and increased awareness of one’s own strengths 
and limitations, rights to have control over personal or family health issues, a voice in decisions 
10 
 
 
directly affecting one’s health, and social and political factors that influence health and health care 
(Falk-Rafael, 2001).   
 Moreover, an increase in knowledge and skills to act correctly on informed choices are also 
interwoven with active participation and increased awareness. They asserted that the process of 
empowerment began internally and it produces a ripple effect that positively affected the family 
members and other individuals that patients interacted with. Therefore, the health care providers are 
also empowered through their patients in a reciprocal effect (Falk-Rafael, 2001). 
 However, mere assumption of equal partnership in disease management is not sufficient to 
empower patients (Paterson, 2001). In health care settings, it is very common for the health care 
providers to discount the experiential knowledge of diabetes patients.  Also, it is very common that 
the health care providers do not provide enough information and skills to support informed decision 
making process of diabetes patients. The health care providers are unable to let go of their own 
agendas, their control in the decision making process, feeling responsible for their patients (Funnell 
& Anderson, 2004; Paterson, 2001).  
 Embracing the philosophy of empowerment and integrating it into practice is easier said than 
done. The health care providers not only need to believe in the empowerment philosophy but also 
need to be aware of their own behaviors and learn to reflect and make necessary changes in their 
practice. Therefore, it takes behavior change and commitment of health care providers in order to 
cultivate a real empowerment approach in diabetes care (B. Anderson & Funnell, 2005; R. Anderson 
& Funnell, 2005; Funnell & Anderson, 2003). In a study from Sweden, the researchers found that 
physicians and nurses needed ongoing support to use an empowerment approach in their practices 
because it was difficult to define their role in the empowerment caring practice and they did not feel 
secure with the new roles (Adolfsson, Smide, Gregeby, Fernström, & Wikblad, 2004). 
 In the health care settings, empowered behaviors of patients are found to be associated with 
healthcare decision-making in terms of knowledge seeking, active involvement in the treatments, and 
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self-treatment (Pierce & Schwartz, 2008, p. 3). A patient-centered collaborative approach in chronic 
illness care has been found to be effective (Wagner, et al., 2001). Research has documented that the 
patient empowerment approach is effective in the diabetes care (Anderson et al., 1995).  
 
(3) Self-Management Education 
 Arnold, Butler, Anderson & Funnell (1995) proposed that as much as 95% of self-care is 
usually provided by the ill persons or their families in diabetes management. In the study by 
O’Connor et al. (2008), it was also found that the 95% of variance in HbA1c control was attributable 
to the patient level such as increased adherence to treatment guidelines or readiness to change (O’ 
Connor et al., 2008).  Diabetes self-management education (DSME) has been recognized as an 
essential component in diabetes care (ADA, 2010b; CDC, 2009; Funnell et al., 2010; National 
Institute of Health, 2008). The National Standard for DSME is designed on the evidence and are 
reviewed and updated every 5 years by a task force from the representatives of the key organizations 
in the field of diabetes education and care (ADA, 2010b; Funnell et al., 2010).  
 However, the actual DSME practice in the diabetes care seems to be very limited.  Even 
though many health care settings are providing self-care management education, there are gaps in 
patient knowledge of diabetes care.  The barriers in self-care management education include poor 
patient-provider communication, low health literacy of patients, low self-efficacy of patients, race, 
cultural and gender issues (Clark, 2008; Leichter, 2005; Gazmararian, Ziemer & Barnes, 2009; 
Odegard & Gray, 2008).  
 Moreover, the requirements of self-care management education for diabetes patients are very 
diverse and therefore, an individualized approach is recommended by national standards of DSME 
(Funnell et al., 2010). To keep the patient’s glycemic index at the desirable level requires knowledge, 
skills, and psychosocial self-efficacy in a diabetes patient. Some basic necessary education includes 
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stress management, nutrition, importance of adherence to medication, significance of exercise and 
physical activity, and self-monitoring of glucose level.  Both hypoglycemia and hyperglycemia can 
cause acute life threatening complications like diabetic ketoacidosis and hyperosmolar nonketotic 
coma.   Patients need to learn how to diagnose, appropriately treat and prevent these life threatening 
complications (Funnell et al., 2010; Funnell & Haas, 1995). In addition to that, they need to learn 
how to prevent, detect and seek treatments for chronic complications. Comorbidities are very 
common in diabetes patients and the care of comorbid diseases cannot be ignored in the DSME 
(Funnell et al., 2010; Funnell & Haas, 1995). 
 Furthermore, a one time education program is rarely effective; patients need on-going self-
management education and support from their providers and the entire diabetes health care team. The 
researchers suggested that diabetes education should aim at a positive attitude to active self-care 
because it was found that patient’s attitude was the most important determinant for active self-care. 
Social environment also has an important influence on the attitude of the patients and a supportive 
atmosphere is very important for the patient with diabetes (de Weerdt, Visser, Kok, & van der Veen, 
1990). The supportive environment can be facilitated through support group formation, educating 
and counseling for family members, as well as creating supportive health care settings.     
 The objective of DMSE within the empowerment philosophy is to help patients to clarify 
their own problems, values and motivations and to identify diabetes related goals they really want to 
achieve in their diabetes care (Anderson et al., 1995; Funnell et al., 1991). To achieve DSME 
objectives, patients need a psychologically safe environment to explore their own emotions. Patients 
also need to have enough information on diabetes care and various treatment options, benefits and 
drawbacks of these options and enough knowledge and skills to change their own behaviors and 
solve their own problems (Arnold et al., 1995). The collaborative goal setting approach is an 
effective strategy in the empowerment-based DSME (Funnell & Anderson, 2004).  
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(4) Goal settings  
 The DSME within this approach enables patients to participate in the decision making 
process, have informed choices, and affords the ability not to blindly comply with or adhere to 
provider-selected goals (Funnell & Anderson, 2004). In general, the goal setting approach was found 
to have beneficial effects such as an increase in motivation and higher performance if they are self-
set and attainable goals. However, conflicts between the provider’s and patient’s goals can cause 
undesirable effects (Locke & Latham, 2002). The collaborated goal setting approach is a solution to 
avoid conflicts between health care provider goals and patient goals.  Goal setting helps both patients 
and providers. For patients, the process creates a sense of accountability and ownership which are 
very important in successful self-care management. For providers, collaborative goal setting helps 
them to identify the barriers to successful treatment (B. Anderson & Funnell, 2005; Langford, 
Sawyer, Gioimo, Brownson, & O'Toole, 2007).  
 Since the patients participate in the selection of goals, they are clear about these goals and 
therefore, more likely to be successful in achieving them (Heisler et al., 2002). Engaging patients in 
the goal setting process not only improves their self-efficacy but also provides emotional support and 
facilitates learning (Funnell & Anderson, 2004). Moreover, goal setting can enhance self-monitoring 
skill of the patient which is an integral part of the behavior change process (Delamater, 2006). 
 Funnell & Anderson identified a five step goal setting empowerment process: 1. explore the 
problem or issue; 2. clarify feelings and meaning; 3. commit to action; 4. experience and 5. evaluate 
the plan (Funnell & Anderson, 2004).  Diabetes educators that have used collaborative goal setting 
approach have found some unexpected barriers to diabetes management (B. Anderson & Funnell, 
2005). Implementing a successful empowerment process takes time, commitment, tolerance, 
understanding of patients’ needs, patient support, and self-directed behavior change by the health 
care providers. Anecdotal evidence provided by diabetes educators and nurses suggests that 
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collaborated goal setting can be an effective part of diabetes management (B. Anderson & Funnell, 
2005; Falk-Rafael, 2001; Langford et al., 2007).  
 
(5) Patient-Provider Communication 
 Provider behavior is a very important part of patient empowerment. Anderson & Funnell 
(1999) said attitude and vision of diabetes educators can influence the outcome of disease 
management. Physician behavior change has the possibility of fostering faster improvement in  
disease management (Solomon, 1995). Patient-centered care is now recognized as a core public 
health professional competency, central to meeting patients’ evolving needs, improving the quality of 
care, and transforming the health care system (Institute of Medicine, 2003). This approach is 
especially important given the ethnic and cultural diversity in the United States (Institute of 
Medicine, 2003).  
 Research suggests that patient-provider interaction styles can influence patients’ self-
management in diabetes care (Heisler, Bouknight, Hayward, Smith, & Kerr, 2002). Physicians who 
used a participatory decision making style of communication can improve patients’ self-care 
management. Patient perception of how well their physicians provide information on their illness and 
treatment were also strongly associated with diabetes self-management (Heisler et al., 2002).  Patient 
understanding of their care was also found to have a strong independent effect on diabetes self-
management (Heisler et al., 2002). Increasing patient motivation and patient engagement in the 
treatment may also be the secondary effect of patient involvement in the decision making process 
which improves the self-care management behavior (Worlpert & Anderson, 2001).  
 Physicians can provide essential basic knowledge needed for their patients to make their own 
decisions about their treatment and self-care priorities. Therefore, measures to promote better 
physician communication and patient understanding can improve patient’s self-management behavior 
15 
 
 
(Heisler et al., 2002). However, many studies found that patients desire to seek more information 
from their physicians are not met. Many patients leave a physician’s office visit without knowing 
how they should take care of themselves (Beisecker & Beisecker, 1990; DiMatteo, 1998).  
In  actual health care settings,  primary care physicians and specialists are often unable to 
give the required amount of time to talk and educate the patient, which are vital to the adherence to 
treatment. Patients should be referred to diabetes educators for additional information and essential 
DSME but that does not always happen in diabetes care. The barrier includes restriction of DSME by 
health insurance providers (Powell, Glover, Probst, & Laditka, 2005).  
 Studies have found that feedback and reminders to providers improve the physicians’ 
adherence to clinical guidelines (Phillips et al., 2002; Schectman, et al., 2004). Receiving patient 
feedback can have an effect on treatment. Improving provider-patient communication can facilitate 
positive health care outcomes by both improving patient adherence to self-care management and 
provider adherence to diabetes management guidelines.  
 
(6) Literacy  
 Since patients need enough knowledge to make rational decisions for their own lives to feel 
empowered, communication materials are regarded as very useful tools for providing knowledge. 
Currently internet-based self care education is being provided by many organizations, but people 
with no or low computer literacy skills and general literacy skills are unable to access them. Printed 
materials are commonly used by health care centers to give additional information to the patients to 
compensate for the limited period of consultation (Mayer & Villaire, 2007).  
 However, communication materials should not be a replacement for the necessary education 
provided by health care providers. A meta-analysis of randomized controlled trial studies on self-
management education for adults with type 2 diabetes found that there is an association between 
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patient and educator contact time and improvement of HbA1c. It is noted that there is a decrease of 
1% HbA1c for every additional 23.6 hours of contact between patients and educators (Norris, Lau, 
Smith, Schmid, & Engelgau, 2002). Therefore, the importance of interpersonal communication 
should not be discounted.  
 Because of health literacy issues, the communication materials should be simple, clear and 
designed for an audience of low reading level. Health literacy is the term used for literacy skills in 
the context of health care (Institute of Medicine, 2004). Literacy skills of Americans range from the 
nonreader to the highly literate. Half the U.S population read at the ninth-grade level or lower and 
most current health care instructions are above that level. About one out of five adult Americans read 
below the fifth-grade level (Doak, Doak & Root, 1996, p. 9).  
 In a study of adult health literacy in urban clinics, almost half of the patients were unable to 
read well enough to follow the instructions for laboratory tests and radiology procedures. Out of 
those patients, 43% denied difficulty in reading (Nurss et al., 1997). In the review by Roter, Rudd, & 
Comings (1998), they also noted that patients did not confess the reading difficulties to their health 
care providers, spouses, family members and friends (Roter et al., 1998).  However, the intelligence 
levels of these patients were not limited and they were able to understand and learn the health 
education information provided by the health care providers (Doak et al., 1996; Nurss et al., 1997). 
Therefore, it is very important to understand and address the literacy issue properly in the 
implementation of patient empowerment interventions in diabetes care.  
  
Areas of Future Research 
 There has been limited research on the comprehensive intervention of patient empowerment.  
Although there are interventions which claim to have a “patient empowerment in diabetes care” 
approach, they are using only some areas of the empowerment model. The interventions are mainly 
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targeted to self-care management education and training of nurses and diabetes educators. Changes in 
attitude and behaviors of physicians are rarely addressed even though it is a very important area in 
the empowerment process.  
 Aujoulat, Luminet, & Deccache (2007) investigated the patient’s experience in the 
empowerment process and they found “powerlessness” of patients in an empowerment care setting 
because the need of empowerment goes beyond medical settings.  These are areas of future research 
because it is imperative to understand methods which can be used to enhance and sustain the 
empowerment of patients. Even though empowerment is a philosophy that is possible to enhance the 
practice of the providers, its effectiveness will depend on the vision and skills of the providers who 
are using it (Anderson & Funnell, 1999). It is important to develop evidence-based interventions by 
using this philosophy in its entirety.  There are many questions to be answered in the patient-
empowerment practices in diabetes care and looking at the association of patient empowerment level 
and desired outcome of metabolic control is an important preliminary step in addressing the 
application of this philosophy to practice. 
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Chapter III 
Methods & Procedures 
 
Primary Data Collection 
Participants 
 Participants in this study were recruited in the Diabetes Clinic of the Grady Health System 
(GHS), Atlanta, Georgia for the intervention study named Patient Empowerment to Improve 
Diabetes Care (PEIDiC). The Endocrinology Division of the Medical Department of the Emory 
University conducted the study in collaboration with the Diabetes Clinic of the Grady Health System. 
The study was funded by ADA.  
 About 50% of patients in the Diabetes Clinic of GHS do not reach their ADA HbA1c goal. 
Ninety percent of first time visitors to the Diabetes Clinic of GHS are African Americans, 61% 
female and 87% have type 2 diabetes with median diabetes duration of 1.3 years. The average patient 
age is 52 years with 80% of patients age 40 and above. Average BMI is 31.7 kg/m2 and 29% are 
overweight and 68% are obese. Patients tend to be economically disadvantaged, less than half have 
any type of health insurance, and literacy levels are low in many patients. Almost half of the patients 
are unable to read well enough to follow instructions for laboratory tests and radiology procedures 
(Barnes, C.S, personal communication, November 12, 2009). 
 For the primary study, eligibility requirements included a) being a patient in the Diabetes 
Clinic of the Grady Health System, b) Type 2 diabetes on insulin, c) and HbA1c greater than 7. 
Exclusion criteria included patients with language barriers or other issues (e.g. mentally impairment) 
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that precluded reliable communication. A total of 828 patients who met the criteria voluntarily 
participated in the study; 450 patients were in the control group and 378 patients were in the 
intervention group.  
 
Procedures 
 The research team of the Endocrinology Division of the Medical Department of the Emory 
University collected the data from June 2005 to June 2008. Recruitment took place at the Diabetes 
Clinic of the GHS. The researchers randomized patients into control group or the intervention group 
based on the last digit of the patient’s medical record number: even digits to intervention group and 
odd digits to the control group. During recruitment, the patients were systematically approached and 
screened for possible participation. Those who choose to consider the study were taken to a private 
room in the Diabetes Clinic. If the patient consented to participate in the study, the pre-intervention 
questionnaires were administered primarily by interview because of the low literacy of many of the 
patients of the Diabetes Clinic of the Grady Health System.  
 While control patients received care as usual, the intervention patients received a) a “real 
time” (current values) road map (Appendix B), b) a communication card (Appendix C), c) coaching 
by a nurse or coach on goal setting of A1c and blood sugar level, and d) instructions on how to use 
these communication tools at home. The real time road map was a visual graphic report on the 
progress of A1c level and random blood glucose (sugar) level of patients over time (usually the last 6 
clinic visits); it was generated by the nurse or coach from the computer at each intervention patient 
visit. A traffic spotlight analogy was used to present the status of glycemic control and the road maps 
were printed in color and given to the patient to post at home. They used red bars to show the 
patient’s glycemic control being  in the danger zone, yellow bars to show the patient’s glycemic 
control  in the caution zone and green bars to show the patient’s glycemic control being  good and 
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normal. It is visually attractive and patient-friendly and an easy to follow progress report on the 
patient’s glycemic control.  
The communication card was a wallet-sized card which contains three questions related to 
A1c: what should my A1c be to stay healthy?; what is my A1c?; and what can we do to get my A1c 
better? The patients in the intervention groups were coached to practice the questions and were 
encouraged to use the card during their visits to the health care providers. The coach and patient, 
together, set diabetes management goals and documented these goals on the road maps. The coach 
helped the patients practice how to ask questions and negotiate goals with their doctors.  
 The panel of questionnaires were collected at 6 month (≥4 to <10 months), 12 month (≥10 to 
<16 month), 18 months (≥16 to <22 months) and 24 months (≥22 to <28 months). The research 
coach recruited participants from month 3 until month 33 of the study period; the duration of 
participation in the study varied from 8 to 26 month depending on the accrual date. All procedures 
were conducted by a trained research nurse or coach and were approved by appropriate Institutional 
Review Boards (IRB).  
 
Measures 
The study measures included data obtained from questionnaires, clinical lab values, self-
report demographics (such as income and education level), and chart review. The data used in this 
sub-analysis included diabetes-related psychosocial self-efficacy measured by the 28-item Diabetes 
Empowerment Scale-Short Form (DES-SF) and the 13-item Patient Activation Measure (PAM).  
DES-SF was developed by the Michigan University Diabetes Research and Training Center 
(Anderson, Funnell, Fitzgerald & Marrero, 2000; Anderson, Fitzgerald, Gruppen, Funnell, & Oh, 
2003; Appendix D). Survey items for the DES-SF began with the common stem, “In general, I 
believe that I…” and sample statements include: “…know what part(s) of taking care of my diabetes 
that I am dissatisfied with,” “…can find ways to feel better about having diabetes,” and “…know 
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enough about myself as a person to make diabetes care choices that are right for me.” Possible 
responses on a 5-point Likert scale ranged from one (Strongly Disagree) to five (Strongly Agree). 
The scale is scored by averaging the scores of all completed items. Reliability and validity data 
provided preliminary evidence that the DES is a valid and reliable measure of overall diabetes-
related psychosocial self-efficacy (Anderson et al., 2003).  
The original questionnaire contained 37 items representing eight conceptual dimensions 
which assessed the need for change, developing a plan, overcoming barriers, asking for support, 
supporting oneself, coping with emotion, motivating oneself, and making diabetes care choices 
appropriate for one’s priorities and circumstances. Using factor analyses the questionnaire was 
reduced to the current 28-item containing these three subscales: 1) managing the psychosocial 
aspects of diabetes with 9 items, 2) assessing dissatisfaction and readiness to change with 9 items, 
and 3) setting and achieving goals with 10 items (Anderson et al., 2003). The total scale score was 
used in this study. 
 PAM was developed by Dr. Judy Hibbard at the University of Oregon (Hibbard, Mahoney, 
Stockard, & Tusler, 2005; Hibbard, Stockard, Mahoney, & Tusler, 2004; Appendix E). The PAM 
score measures the knowledge, skills and confidence for managing one’s own health and healthcare. 
It is generally used as a measure of patient empowerment in managing healthcare and disease status. 
The version used in the PEIDiC study is a shortened 13-item instrument which is down from the 
original 22-item that specifically deals with patients suffering from chronic conditions like diabetes. 
The Patient Activation Measure is scored by summing the 13 question survey (Hibbard et al., 2005). 
Each question used a Likert-type agreement scale with four possible answers: disagree strongly, 
disagree, agree and agree strongly.  If one or two questions were missing answers the score was 
computed from the available answers and scaled up to represent the score from the 13-item 
questionnaire. If more than two answers were missing then the whole test is regarded as a missing a 
score (Hibbard et al., 2005). The raw score was converted to a theoretical 0 to 100 scale with 0 being 
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the lowest activation and 100 being the highest. This score is also reported as one of four 
corresponding levels of activation with the lowest level being the least empowered. 
Levels of Activation are categorized as follows: 
Stage 1- “Starting to Take a Role” (score ≤47): Patient does not yet grasp that they must take an 
active role in their health. 
Stage 2- “Building Knowledge and Confidence” (score≥47.1 and ≤55.1): Patient lacks the basic facts 
or has not connected these facts into a larger understanding of their health. 
Stage 3- “Taking Action” (score ≥55.2 and ≤67.0): Patients have the key facts and are beginning to 
take action but may still lack confidence. 
Stage 4- “Maintaining Behaviors” (score ≥67.1): Patients have adopted new behaviors but are still 
working to maintain these under stress or crises (Rask et al., 2009).  
 The Patient Activation Measure was developed using Rasch analyses and is an interval level, 
Guttman like measure. Validity has generally been shown by demonstrating that patients falling into 
a specific activation stage could be categorized the same way by independent judges who looked at 
interviews done with the patients (Hibbard et al., 2005; Hibbard et al., 2004).  Previous research has 
shown that higher PAM scores indicate better adherence to medication, more self-management 
behaviors, and healthier behaviors (Hibbard, Mahoney, Stock, & Tusler, 2007; Mosen, Schmittdiel, 
Hibbard, Sobel & Remmers, 2007; Rask et al., 2009). 
 The knowledge level of patients on diabetes management was measured by a non-
standardized questionnaire. In the questionnaire, the knowledge level of HbA1c is measured by the 
question “what should your A1c be?” Based on the responses, the patients were divided into three 
groups: patients who know the correct A1c goal; patients who do not know correct A1c goal but 
recognized the A1c term; patients who did not recognized the term A1c.  
 The socio-demographic data, clinical data and laboratory data were collected from the 
existing Diabetes Patient Tracking System (DPTS). DPTS was implemented in the GHS in 1991. It is 
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an electronic database with feedback, reporting and decision support modules used to track patient 
outcomes. Clinical data from every diabetic visit to the Medical and Diabetes Clinic of the GHS were 
manually entered. Laboratory and administrative data were obtained by electronic transfer from GHS 
main laboratory. Therapy and disease markers, such as A1c, blood pressure, and lipid profiles can be 
linked to a single patient and monitored overtime.  
 
Secondary Data Analysis 
 The data from PEIDiC randomized controlled longitudinal intervention study were provided 
for this analysis by the Diabetes Clinic of the GHS and by the research team of the Endocrinology 
Division of the Medical Department of the Emory University. The data were de-identified through 
the removal of identifiers such as patient medical record numbers, date of birth and addresses. This 
study was approved by the Georgia State University IRB. 
 
Eligibility 
 As stated, 828 patients participated in the study and their data were incorporated into the data 
set. After non-African American patients were omitted from the study, 786 patients were left for this 
analysis. Of these 786 patients, 529 patients who have complete DES and PAM score and HbA1c 
data for the study period were used for this study.  
 
Study Variables 
 The cross-sectional data analysis utilized three dependent variables: Diabetes Empowerment 
Score which is the summary score from the 28-item DES-SF, the summary score from the 13-item 
PAM, and the HbA1c level of each patient. Patients in the intervention group received additional 
individualized coaching, real time road map and HbA1c communication cards as stated and patients 
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in the control group received Diabetes Clinic Standard care. The independent variables were the 
intervention and demographic factors of age, gender, educational attainment and income level. 
 
Data Management 
 SPSS Version 16.0 was utilized for data management and statistical analysis purposes. Age 
was recoded from a continuous variable to the categorical variables of “50 and younger”, “51-64” 
and “65 and older”. Educational attainment was recoded from 6 categories to 3 categories which 
were “lower than high school graduate level”, “high school graduate or GED” and “some college or 
technical school and higher”.  
Socioeconomic status or income level was recoded from 10 categories to 3 categories which were 
“income less than $5,000”, “income between $5,000 to $9,999” and “income $10,000 and more”. 
 
Statistical Analysis 
 Descriptive analyses were conducted on the demographic variables of age, gender, 
educational attainment, employment, marital status, income level and other patient characteristics 
such as Body Mass Index (BMI), duration of diabetes, insulin use, HbA1c level, DES score and 
PAM score at the baseline level. The mean and standard deviations (SD) were computed for all the 
continuous variables while frequencies and percentages were computed for all categorical variables. 
Additional descriptive analyses were conducted to compare the control group and intervention group 
on these variables at baseline.  
 Two-Way ANOVA was conducted on DES score, PAM score and HbA1c level at the 
baseline and 12 month study period and with intervention group and demographic characteristics as 
independent variables. The mean and SD were computed for all variables. These analyses were 
conducted for descriptive purposes in order to describe these variables with respect to different levels 
of age, gender, educational attainment and income level.  
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Correlation 
 Pearson correlation was conducted to determine the degree of association of the dependent 
variables, (for example, HbA1c with DES and PAM scores overall as a group, at different 
intervention periods and by study group). These analyses were also stratified at by levels of age, 
gender, educational attainment and income. 
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Chapter IV 
Results 
 
 The overall sample was 63.3% female and 66% reported an education level greater than or 
equal to high school graduate or GED. Only 16.5% of the overall sample was married and only 9.5% 
were employed full-time. The insulin use for the treatment of diabetes at the baseline level was 
95.7% for the overall sample. Mean age was 55.6 years (SD = 11.37) and mean BMI of the overall 
sample was 34.6 (SD = 8.54, N = 519). Mean duration of diabetes of the overall sample was 10.8 
years (SD = 8.12). Mean baseline HbA1c of the overall sample was 8.6% (SD = 2.10), mean baseline 
DES score of the overall sample was 4.2 (SD = 0.69) and mean baseline PAM score of the overall 
sample was 74.3 (SD = 16.48). The two treatment groups did not differ on any of these variables at 
the baseline assessment. However, the two groups did differ (p = 0.013) on income with the 
intervention group having a slightly higher percent (41.7%) in the upper income category compared 
to the control group (34.9%). 
 Two-Way ANOVAs were utilized to understand how HbA1c, DES scores and PAM scores 
differed between the study groups at the baseline and 12 month intervention period. Analyses were 
cross-sectional and the samples were stratified by age, gender, income and educational attainment to 
assess effect modification.  
 As seen in Table 2a, HbA1c did not appear to differ between the treatment and the control 
groups at the baseline and 12 month assessments. However, the mean HbA1c of both treatment and 
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control group at the 12 month appeared to be lower than mean HbA1c of baseline at the different 
levels of age groups. 
 The result of a Two-Way ANOVA with baseline HbA1c as the dependent variable and 
treatment group and age group as independent variables indicated a significant main effect for age 
group (F(2, 523) = 9.11, p < 0.001), but no effects for either the treatment group main effects or the 
treatment by age group interaction. Based on the Tukey’s post hoc test, mean HbA1c was 
significantly higher in the <50 age group compared to both the 51-64 age group (p = 0.01) and ≥ 65 
age group (p < 0.001). The means for the two other age groups did not differ significantly. The result 
of a Two-Way ANOVA with 12 month HbA1c as the dependent variable and treatment group and 
age group as independent variable indicated a significant main effect for age group (F(2, 316) =  
6.53, p = 0.002) but no effects for either two treatment groups or the treatment by age group 
interaction. Based on the Tukey’s post hoc test, mean HbA1c was significantly higher in the <50 age 
group compared to the ≥ 65 age group (p = 0.001). The means for the other age groups did not differ 
significantly. As seen in Table 2b, the mean HbA1c of the both treatment and control groups at the 
12 month appeared to be lower than mean HbA1c of baseline at all the different levels of age groups.  
 The results of Two-Way ANOVAs with baseline and 12 month HbA1c as the dependent 
variables and treatment group and gender as independent variables indicated  no statistically 
significant effects for either the main effects or the interaction effect. As seen in Table 2c, the mean 
HbA1c of both treatment and control groups at the 12 month appeared to be lower than mean HbA1c 
of baseline for both genders.  
 The results of Two-Way ANOVAs with baseline and 12 month HbA1c as the dependent 
variable and treatment group and income as independent variables indicated no statistically 
significant effects for either the main effects or the interaction effect. As seen in Table 2d, the mean 
HbA1c of both treatment and control groups at the 12 month appeared to be lower than mean HbA1c 
of baseline at all the different levels of income.  
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 The results of Two-Way ANOVAs with baseline and 12 month HbA1c as the dependent 
variable and treatment group and educational attainment as independent variables indicated no 
statistically significant effects for either the main effects or the interaction effect. As seen in Table 
2e, mean HbA1c of  both the treatment and control group at the 12 month appeared to be lower than 
mean HbA1c of baseline at all the different levels of educational attainment except in the control 
group for those with  some college or technical school and higher where the values were very similar. 
 As seen Table 3a, DES scores did not appear to differ between the treatment and the control 
groups at baseline and 12 month. The result of a Two-Way ANOVA with baseline DES scores as the 
dependent variable and treatment group and age group as independent variables indicated a 
significant main effect for age group (F(2, 523) = 3.675, p = .026) and significant interaction effect 
for age group and treatment group (F(2, 523) = 4.161, p = .016). There was no main effect for 
treatment group. Based on  Tukey’s post hoc test, mean DES score was significantly higher in the  
51to 64 age group compared to ≥ 65 age group in the control groups (p = 0.011) and it was 
significantly higher in the  < 50 age group compared to 51to 64 age group in the intervention groups 
(p = 0.025). The means for the other age groups did not differ significantly at the baseline. 
 The results of a Two-Way ANOVA with 12 month DES scores as the dependent variable and 
treatment group and age as independent variables indicated no statistically significant effects for 
either the main effects or the interaction effect. As seen Table 3b, DES scores did not appear to differ 
between the treatment and the control groups at baseline and 12 month of the intervention period at 
any age groups except at the ≥ 65 age group which appeared have higher DES score in the 
intervention group at the 12 month.  
 The results of Two-Way ANOVAs with baseline and 12 month DES scores as the dependent 
variable and treatment group and gender as independent variables indicated no statistically 
significant effects for either the main effects or the interaction effect. As seen in Table 3c, DES 
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scores of the study groups at 12 month did not appear to differ from DES scores at baseline for either 
gender.  
 The result of a Two-Way ANOVA with baseline DES score as the dependent variable and 
treatment group and income as independent variables indicated a significant main effect for income 
(F(2, 498) = 4.094, p = 0.017) but no effects for either treatment group or the treatment by age group 
interaction. Based on  Tukey’s post hoc test, mean DES score was significantly higher in the  
≥$10,000 income group compared to $5,000 to $9,999 group (p = 0.023). The means for the other 
income groups did not differ significantly at the baseline. The results of a Two-Way ANOVA with 
12 month DES scores as the dependent variable and treatment group and income as independent 
variables indicated no statistically significant effects for either the main effects or the interaction 
effect. As seen in Table 3d, DES scores did not appear to  differ between the treatment and the 
control groups at baseline and 12 month of the intervention period at any income levels.  
 The result of a Two-Way ANOVA with baseline DES scores as the dependent variable and 
treatment group and educational attainment as independent variables indicated a significant main 
effect for educational attainment (F(2, 521) = 5.949, p = 0.003) and significant interaction effect for 
educational attainment and treatment group (F(2, 521) = 3.438, p = 0.033). There was no main effect 
for treatment group. Based on the Tukey’s post hoc test, mean DES score was significantly higher in 
the  some college or technical school and above group compared to the mean DES scores of lower 
than high school graduate level group (p = 0.009) and high school graduate or GED group (p = 
0.001) in the intervention groups. The means between the other educational attainment groups did 
not differ significantly. 
 The results of a Two-Way ANOVA with 12 month DES scores as the dependent variable and 
treatment group and educational attainment as independent variables indicated no statistically 
significant effects for either the main effects or the interaction effect. As seen in Table 3e, DES 
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scores did not appear to differ between the treatment and the control groups at baseline and 12 month 
of the intervention period at any levels of educational attainment. 
 As seen in Tables 4a to 4e, the results of Two-Way ANOVA with baseline and 12 month 
PAM scores as the dependent variables and treatment group and age, gender, income, or educational 
attainment as independent variables indicated that there were no statistically significant effects for 
either the main effects or the interaction effects. As seen in Tables 4a to 4e, PAM scores appeared to 
be higher at the12 month  period in both treatment and the control groups. 
 In order to understand the association between DES score and HbA1c and PAM score and 
HbA1c, Pearson’s correlations were utilized to determine the degree of association of these variables 
at the baseline, 6 month and 12 month intervention periods. The sample was also stratified by age, 
gender, income and educational attainment to assess confounding and effect modification. A seen in 
Table 5a, a negative association between DES score and HbA1c was found in the intervention group 
at the 6 month period of intervention at p < 0.05 level (r (132) = -0.21, p = 0.014) but there was no 
other significant association in the other groups. As seen in Table 5b, a negative association between 
DES score and HbA1c was found in the intervention group age more than or equal to 65 at the 6 
month period of intervention at p < 0.01 level (r (31) = -0.52, p = 0.003) and no other significant 
association between DES score and HbA1c was found in any other groups.  
 As seen in Table 5c, a negative association between DES score and HbA1 was found in the 
intervention group female  at the 6 month period of intervention at p < 0.01 level (r (89) = -0.31, p = 
0.003) but there were no other significant associations in the other groups. As seen in Table 5d, a 
negative association between DES score and HbA1c was found in the control group with income of 
$5,000 to $9,999 at the 12 month period  at p < 0.05 level (r (34) = -0.42, p = 0.015) but there were 
no other significant association between DES score and HbA1c in any other groups.  
 As seen in Table 5e, a negative association between DES score and HbA1c was found in the 
control group who had some college or technical school or higher level of educational attainment at 
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the 6 month period  at p < 0.05 level (r (30) = -0.38, p = 0.036). There was also a negative 
association between DES score and HbA1c in the intervention group who were high school graduate 
or GED at the 6 month period at p < 0.01 level (r (62) = -0.36, p = 0.004). There were also a possible 
negative association between DES score and HbA1c in the intervention group who had some college 
or technical school or higher level of educational attainment at the 6 month period but it was not 
significant (r (31) = -0.32, p = 0.083). Apart from these, no other significant associations between 
DES score and HbA1c were found in the analyses. 
 Although many Pearson’s correlations coefficients between DES score and HbA1c were not 
significant, there was a pattern of weak negative association between the DES score and HbA1c in 
the correlation matrix. It seems to support hypothesis I which said DES score in diabetes care is 
negatively associated with the HbA1c level of diabetes patient. 
 As seen in Table 6a, there was no significant association between PAM score and HbA1c 
level in the treatment groups at both baseline and the 12 month period. As seen in Table 6b, a 
negative association between PAM score and HbA1c was found in the intervention group at the 6 
month  period for those ≤ 50 years of age at p < 0.05 level (r (37) = -0.37, p = 0.025) but there were 
no significant associations between PAM score and HbA1c at the other intervention periods or other 
age groups.  
 As seen in Tables 6b to 6d, there were no significant associations between PAM score and 
HbA1c of the treatment groups by gender and different levels of income groups at baseline, 6 month 
and 12 month intervention periods. As seen in Table 6e, a negative association between PAM score 
and HbA1c was found in the intervention group at the 12 month  period of the study group with 
lower than high school graduate level of educational attainment at p < 0.05 level (r (22) = -0.45, p = 
0.034).  
 Although many Pearson’s correlation coefficients between PAM score and HbA1c were not 
significant, there was a pattern of weak negative association between the PAM score and HbA1c in 
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the correlation matrix. It seems to support hypothesis II which said PAM scores in diabetes care is 
negatively associated with the HbA1c level of diabetes patients. 
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Table 1: Descriptive characteristics of the study sample at baseline 
 
Variables Overall 
N = 529 
 
Control 
N = 287 
 
Intervention 
N = 242 
 
P-Values 
Female (%) 63.3 63. 6 62.8 0.844 
Married (%) 16.5 16.1 17 0.881 
High School 
Graduate or GED 
and above (%) 
66 63.3 69.3 0.291 
Employed full-
time (%) 
9.5 8.7 10.3 0.890 
Total Household 
Income (%) 
   0.013 
<$5,000 
 
33.9 31.6 36.6  
$5,000 -$9,999 
 
28.0 33.5 21.7  
≥ $10,000 38.1 34.9 41.7  
Age (years)  
Mean (SD) 
55.6 (11.37) 56.2 (11.59) 54.8 (11.08) 0.156 
BMI  
Mean (SD) 
34.6 (8.54) 34.7 (8.71) 34.5 (8.35) 0.825 
Duration of 
diabetes (years)  
Mean (SD) 
10.8 (8.12) 10.4 (8.00) 11.3 (8.24) 0.226 
Baseline Hb A1c 
(%) 
Mean (SD) 
8.6 (2.10) 8.5 (2.10) 8.7 (2.08) 0.265 
Baseline DES 
score Mean (SD)  
4.2 (0.69) 4.2 (0.70) 4.1 (0.67) 0.632 
Baseline PAM 
score  
Mean (SD) 
74.3 (16.48) 74.8 (15.79) 73.7 (17.28) 0.430 
Using Insulin at 
baseline (%) 
95.7 96.9 94.2 0.313 
Note: BMI overall N= 519, Control N= 279, Intervention N= 240. One person did not report gender. 
 
 
Table 2a: HbA1c levels at baseline and 12 month in different study groups 
 
 Baseline  
Mean (SD), N 
12 month 
Mean (SD), N 
Control 8.5 (2.10), 287 8.0 (2.10), 178 
Intervention 8.7 (2.08), 242 8.0 (1.77), 144 
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Table 2b: HbA1c levels at baseline and 12 month in different study groups stratified by age  
 
  Baseline  
Mean (SD), N 
12 month 
Mean (SD), N 
 ≤50 Control 9.1 (2.43), 83 8.7 (2.94), 42 
Intervention 9.2 (2.53), 82 8.5 (2.19), 41 
51-64 Control 8.4 (1.97), 131 8.0 (1.95), 79 
Intervention 8.7 (1.83), 111 7.9 (1.52), 68 
 ≥ 65 Control 8.1 (1.81), 73 7.5 (1.31), 57 
Intervention 8.1 (1.57), 49 7.5 (1.58), 35 
Note: According to the Tukey’s tests, mean HbA1c was significantly higher in the  < 50 age group 
compared to both the 51-64 age group (p = 0.01) and  ≥  65 age group (p  < 0.001) at baseline and 
mean HbA1c was significantly higher in the <50 age group compared to the  ≥ 65 age group (p = 
0.001) at 12 month. 
 
 
Table 2c: HbA1c levels at baseline and 12 month in different study groups stratified by gender  
 
  Baseline  
Mean (SD), N 
12 month 
Mean (SD), N 
Male Control 8.6 (2.30), 104 8.4 (2.67), 58 
Intervention 9.1 (2.32), 90 8.2 (1.71), 55 
Female Control 8.5 (1.98), 182 7.9 (1.75), 119 
Intervention 8.6 (1.90), 152 7.9 (1.80), 89 
 
 
Table 2d: HbA1c levels at baseline and 12 month in different study groups stratified by income 
 
  Baseline  
Mean (SD), N 
12 month 
Mean (SD), N 
<$5,000 Control 8.9 (2.32), 85 8.3 (2.30), 50 
Intervention 8.8 (2.02), 86 8.1 (1.69), 51 
$5,000 - 
$9,999 
Control 8.5 (2.02), 90 7.8 (2.05), 58 
Intervention 8.5 (2.05), 51 8.0 (2.03), 35 
≥ $10,000 Control 8.2 (1.78), 94 8.0 (2.00), 62 
Intervention 8.8 (2.10), 98 7.8 (1.59), 56 
 
 
 
 
 
 
 
35 
 
 
Table 2e: HbA1c levels at baseline and 12 month in different study groups stratified by 
educational attainments 
 
  Baseline  
Mean (SD), N 
12 month 
Mean (SD), N 
lower 
than high 
school 
graduate 
level 
Control 8.6 (2.13), 105 7.9 (2.06), 67 
Intervention 8.5 (1.75), 74 7.9 (1.69), 49 
high 
school 
graduate 
or GED 
Control 8.5 (2.21), 107 7.9 (1.74), 72 
Intervention 8.8 (2.10), 104 8.2 (1.87), 61 
some 
college or 
technical 
school 
and 
higher 
Control 8.5 (1.94), 74 8.5 (2.72), 38 
Intervention 9.0 (2.37), 63 7.8 (1.71), 34 
 
 
Table 3a: DES scores at baseline and 12 month in different study groups 
 
 Baseline  
Mean (SD), N 
12 month 
Mean (SD), N 
Control 4.2 (0.70), 287 4.1 (0.62), 120 
Intervention 4.1 (0.67), 242 4.2 (0.59), 100 
 
 
Table 3b: DES scores at baseline and 12 month in different study groups stratified by age  
 
  Baseline  
Mean (SD), N 
12 month 
Mean (SD), N 
 ≤50 Control 4.2 (0.75), 83 4.2 (0.57), 26 
Intervention 4.3 (0.60), 82 4.3 (0.54 ), 31 
51-64 Control 4.3 (0.65), 131 4.2 (0.53 ), 59 
Intervention 4.0 (0.70), 111 4.2 (0.63), 43 
 ≥ 65 Control 4.0 (0.71), 73 3.9 (0.72), 35 
Intervention 4.0 (0.65), 49 4.3 (0.60), 26  
Note: According to the Tukey’s test, mean DES score was significantly higher in the  51to 64 age 
group compared to ≥  65 age group in the control groups (p = 0.011) and it was significantly higher 
in the  < 50 age group compared to 51to 64 age group in the intervention groups (p = 0.025) at 
baseline. 
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Table 3c: DES scores at baseline and 12 month in different study groups stratified by gender  
 
  Baseline  
Mean (SD), N 
12 month 
Mean (SD), N 
Male Control 4.2 (0.71), 104 4.1 (0.62), 47 
Intervention 4.2 (0.66), 90 4.2 (0.59), 38 
Female Control 4.2 (0.70), 182 4.1 (0.62), 72 
Intervention 4.1 (0.67), 152 4.2 (0.60), 62 
 
 
Table 3d: DES scores at baseline and 12 month in different study groups stratified by income   
 
  Baseline  
Mean (SD), N 
12 month 
Mean (SD), N 
<$5,000 Control 4.2 (0.75), 85 4.1 (0.51), 36 
Intervention 4.1 (0.73), 86 4.1 (0.68), 37 
$5,000 - 
$9,999 
Control 4.1 (0.70), 90 4.0 (0.68), 38 
Intervention 4.0 (0.69), 51 4.1 (0.58), 23 
≥ $10,000 Control 4.3 (0.63), 94 4.2 (0.64), 43 
Intervention 4.2 (0.60), 98 4.3 (0.49), 38 
Note: According to the Tukey’s test, mean DES score was significantly higher in the ≥ $10,000 
income group compared to $ 5,000 to $ 9,999 group (p = 0.023) at baseline. 
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Table 3e: DES scores at baseline and 12 month in different study groups stratified by 
educational attainments 
 
  Baseline  
Mean (SD), N 
12 month 
Mean (SD), N 
lower 
than high 
school 
graduate 
level 
Control 4.1 (0.75), 105 4.0 (0.68), 44 
Intervention 4.1 (0.72), 74 4.2 (0.50), 24 
high 
school 
graduate 
or GED 
Control 4.2 (0.66), 107 4.2 (0.55), 51 
Intervention 4.0 (0.69), 104 4.2 (0.68), 51 
some 
college or 
technical 
school 
and 
higher 
Control 4.2 (0.68), 74 4.15 (0.62), 25 
Intervention 4.4 (0.46), 63 4.3 (0.53), 25 
Note: According to the Tukey’s test, mean DES score was significantly higher in the  some college 
or technical school and above group compared to the mean DES scores of lower than high school 
graduate level group (p = 0.009) and high school graduate or GED group (p = 0.001) in the 
intervention groups at baseline. 
 
 
Table 4a: PAM scores at baseline and 12 month in different study groups 
 
 Baseline  
Mean (SD), N 
12 month 
Mean (SD), N 
Control 74.8 (15.79), 287 78.1 (14.81), 120 
Intervention 73.7 (17.28), 242 78.4 (17.35), 98 
 
 
Table 4b: PAM scores at baseline and 12 month in different study groups stratified by age  
 
  Baseline  
Mean (SD), N 
12 month 
Mean (SD), N 
 ≤50 Control 74.1 (15.33), 83 78.8 (16.65), 26 
Intervention 75.0 (18.74), 82 79.4 (16.57), 31 
51-64 Control 77.4 (15.34), 131 80.4 (14.04), 59 
Intervention 73.3 (16.55), 111 77.6 (17.75), 43 
 ≥ 65 Control 71.1 (16.46), 73 73.6 (14.06), 35 
Intervention 72.3 (16.55), 49 78.4 (18.25), 24 
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Table 4c: PAM scores at baseline and 12 month in different study groups stratified by gender 
 
  Baseline  
Mean (SD), N 
12 month 
Mean (SD), N 
Male Control 76.0 (14.82), 104 77.4 (17.02), 47 
Intervention 73.4 (17.64), 90 77.9 (18.35), 38 
Female Control 74.1 (16.33), 182 78.5 (13.38), 72 
Intervention 73.9 (17.12), 152 78.6 (16.83), 60 
 
 
Table 4d: PAM scores at baseline and 12 month in different study groups stratified by income  
 
  Baseline  
Mean (SD), N 
12 month 
Mean (SD), N 
<$5,000 Control 75 (16.42), 85 79.8 (15.65), 36 
Intervention 70.6 (18.13), 86 79.8 (19.52), 37 
$5,000 - 
$9,999 
Control 75.3 (15.97), 90 73 (15.13), 38 
Intervention 76.2 (14.41), 51 73.3 (16.66), 23 
≥ $10,000 Control 75.9 (15.16), 94 81.4 (13.17), 43 
Intervention 75.1 (17.30), 98 79.9 (15.65), 36 
 
 
Table 4e: PAM scores at baseline and 12 month in different study groups stratified by 
educational attainments 
 
  Baseline  
Mean (SD), N 
12 month 
Mean (SD), N 
lower 
than high 
school 
graduate 
level 
Control 73.4 (17.31), 105 75.7 (13.24), 44 
Intervention 72.6 (18.64), 74 76.6 (16.91), 23 
high 
school 
graduate 
or GED 
Control 75.7 (15.93), 107 79.8 (16.17), 51 
Intervention 72.7 (16.35), 104 78.4 (18.59), 50 
some 
college or 
technical 
school 
and 
higher 
Control 75.5 (13.23), 74 78.9 (14.52), 25 
Intervention 77.1 (16.63), 63 80 (15.57), 25 
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Table 5a: Correlations between DES scores and HbA1c levels at different time periods in 
different study groups 
 
 DES scores 
Hb A1c Baseline 
r(n) 
6 month 
r(n) 
12 month 
r(n) 
Overall 0.04  (529) -0.09 (280) -0.084 (206) 
Control 0.041 (287) 0.02 (148) -0.07 (112) 
Intervention 0.04 (242) -0.21 (132)* -0.01 (94) 
*. Correlation is significant at the 0.05 level (2-tailed). 
 
 
Table 5b: Correlations between DES scores and HbA1c levels at different time periods in 
different study groups stratified by age  
 
 DES scores 
Hb A1c Baseline  6 month 12 month 
 Control 
r(n) 
Intervention 
r(n) 
Control 
r(n) 
Intervention 
r(n) 
Control 
r(n) 
Intervention 
r(n) 
≤50 0.06 (83) 0.11 (82) -0.16 (42) -0.11 (36) -0.17 (24) -0.16 (29) 
51-64 -0.04 (131) -0.06 (111) 0.09 (63) -0.19 (65) -0.09 (56) -0.26 (42) 
 ≥ 65 0.11 (73) -0.04 (49) 0.09 (43) -0.52 (31)** -0.03 (32) 0.21 (23) 
**. Correlation is significant at the 0.01 level (2-tailed). 
 
 
Table 5c: Correlations between DES scores and HbA1c levels at different time periods in 
different study groups stratified by gender 
 
 DES scores 
Hb A1c Baseline  6 month 12 month 
 Control  
r(n) 
Intervention 
r(n) 
Control 
r(n) 
Intervention 
r(n) 
Control 
r(n) 
Intervention 
r(n) 
Male 0.06 (104) 0.08 (90) 0.03 (54) -0.07 (43) -0.22 (42) -0.20 (37) 
Female 0.03 (182) -0.00 (152) 0.06 (93) -0.31 (89)** 0.31 (69) -0.05 (57) 
**. Correlation is significant at the 0.01 level (2-tailed). 
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Table 5d: Correlations between DES scores and HbA1c levels at different time periods in 
different study groups stratified by income  
 
 DES scores 
Hb A1c Baseline  6 month 12 month 
 Control 
r(n) 
Intervention 
r(n) 
Control 
r(n) 
Intervention 
r(n) 
Control 
r(n) 
Intervention 
r(n) 
<$5,000 -0.11 (85) 0.19 (86) 0.11 (46) -0.24 (49) 0.08 (33) -0.21 (36) 
$5,000 -
$9,999 
0.20 (90) -0.18 (51) 0.05 (42) 0.06 (29) -0.42 (34)* -0.34 (20) 
≥ $10,000 0.13 (94) 0.02 (98) -0.00 (55) -0.19 (52) -0.02 (42) 0.15 (36) 
*. Correlation is significant at the 0.05 level (2-tailed). 
 
 
Table 5e: Correlations between DES scores and HbA1c levels at different time periods in 
different study groups stratified by educational attainments 
 
 DES scores 
Hb A1c Baseline  6 month 12 month 
 Control 
r(n) 
Intervention 
r(n) 
Control 
r(n) 
Intervention 
r(n) 
Control 
r(n) 
Intervention 
r(n) 
lower 
than high 
school 
graduate 
level 
0.02 (105) -0.04 (74) 0.06 (49) 0.05 (39) 0.08 (41) 0.13 (23) 
high 
school 
graduate 
or GED 
0.12 (107) 0.07 (104) 0.22 (68) -0.36 (62)** -0.15 (48) -0.09 (47) 
some 
college or 
technical 
school 
and 
higher 
-0.05 (74) 0.05 (63) -0.38 (30)* -0.32 (31) -0.22 (23) -0.26 (24) 
*. Correlation is significant at the 0.05 level (2-tailed). 
**. Correlation is significant at the 0.01 level (2-tailed). 
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Table 6a: Correlations between PAM scores and HbA1c levels at different time periods in 
different study groups 
 PAM score 
Hb A1c Baseline 
r(n) 
6 month 
r(n) 
12 month 
r(n) 
Overall -0.03 (529) -0.06 (278) -0.04 (204) 
Control -0.02 (287) 0.02 (147) -0.03 (112) 
Intervention -0.03 (242) -0.15 (131) -0.05 (92) 
 
 
Table 6b: Correlations between PAM scores and HbA1c levels at different time periods in 
different study groups stratified by age  
 
 PAM score 
Hb A1c Baseline  6 month 12 month 
 Control Intervention Control Intervention Control Intervention 
≤50 0.04 (83) 0.01 (82) -0.20 (41) -0.37 (37)* 0.06 (24) -0.20 (29) 
51-64 -0.08 (131) -0.10 (111) 0.15 (63) 0.00 (63) -0.19 (56) 0.06 (42) 
 ≥ 65 -0.02 (73) -0.06 (49) -0.00 (43) -0.28 (31) 0.08 (32) 0.09 (21) 
*. Correlation is significant at the 0.05 level (2-tailed). 
 
 
Table 6c: Correlations between PAM scores and HbA1c levels at different time periods in 
different study groups stratified by gender 
 
 PAM score 
Hb A1c Baseline  6 month 12 month 
 Control 
r(n) 
Intervention 
r(n) 
Control 
r(n) 
Intervention 
r(n) 
Control 
r(n) 
Intervention 
r(n) 
Male -0.09 (104) -0.06 (90) 0.01 (53) -0.20 (43) -0.04 (42) 0.04 (37) 
Female 0.02 (182) -0.01 (152) -0.01 (93) -0.12 (88) 0.00 (69) -0.11 (55) 
 
 
Table 6d: Correlations between PAM scores and HbA1c levels at different time periods in 
different study groups stratified by income  
 
 PAM score 
Hb A1c Baseline  6 month 12 month 
 Control 
r(n) 
Intervention 
r(n) 
Control 
r(n) 
Intervention 
r(n) 
Control 
r(n) 
Intervention 
r(n) 
<$5,000 -0.16 (85) 0.14 (86) -0.01 (45) -0.28 (48) 0.21 (33) 0.08 (36) 
$5,000 -
$9,999 
0.03 (90) -0.16 (51) 0.05 (41) -0.16 (28) -0.14 (34) -0.10 (20) 
≥ $10,000 0.15 (94) -0.05 (98) 0.01 (56) -0.02 (52) -0.29 (42) -0.19 (34) 
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Table 6e: Correlations between PAM scores and HbA1c levels at different time periods in 
different study groups stratified by educational attainments 
 
 PAM score 
Hb A1c Baseline  6 month 12 month 
 Control 
r(n) 
Intervention 
r(n) 
Control 
r(n) 
Intervention 
r(n) 
Control 
r(n) 
Intervention 
r(n) 
lower 
than high 
school 
graduate 
level 
-0.13 (105) 0.05 (74) 0.16 (49) -0.02 (38) 0.20 (41) 0.45 (22)* 
high 
school 
graduate 
or GED 
0.09 (107) -0.05 (104) 0.06 (67) -0.16 (63) 0.06 (48) -0.19 (46) 
some 
college or 
technical 
school 
and 
higher 
-0.00 (74) -0.08 (63) -0.22 (30) -0.30 (30) -0.36 (23) -0.00 (24) 
*. Correlation is significant at the 0.05 level (2-tailed). 
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Chapter V  
Discussion & Conclusion 
 
Discussion 
 Diabetes is a costly complex disease to manage, and therefore, its burden in the United States 
is great (CDC, 2009; ADA, 2008).  Because the prevalence, morbidity and mortality rates of diabetes 
are higher for African Americans as compared to their white counterparts, they carry a higher share 
of the burden of diabetes (U.S Department of Health and Human Services, 2009). Racial disparities 
in access to health care, health literacy problems, socio economic factors, beliefs, behaviors, 
lifestyles and other cultural issues suggest patient empowerment can be a solution to these problems 
(Dreeben, 2001; Greene et al., 2006, Liburd, 2010). 
 Patient empowerment is a philosophy which is changing the medical paradigm from the 
traditional provider-centered medical care model to the patient-centered care model (Funnell & 
Anderson, 2004). The patient-centered care has been tested and shown effective in chronic illness 
care (Wagner et al., 2001). In current diabetes care, the patient empowerment model is used mainly 
in DSME and nursing care (B. Anderson & Funnell, 2005; Falk-Rafael, 2001). Individualized 
education based on assessment and planning collaboratively with patients, an important area of 
patient empowerment, has been suggested as one of the standards of national DSME guidelines 
(Funnell et al., 2010).  
 However, many other areas are needed to be considered to fully empower a patient. To 
encourage the patient’s autonomy of their own care, health care providers should integrate the patient 
empowerment philosophy into their practice (B. Anderson & Funnell, 2005; R. Anderson & Funnell, 
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2005). In addition to that, health care providers need a supportive environment to foster a patient 
empowerment approach because letting go of control in  disease management is not an easy task for 
them (Adolfsson et al., 2004). Furthermore, patient’s powerlessness goes beyond medical settings 
and it is important to identify problems of powerlessness and to find ways to address these identified 
problems (Aujoulat et al., 2007). 
 Even though there are studies on certain important parts of patient empowerment in diabetes 
care, there are still gaps in fully understanding the implications of patient empowerment. Trainings, 
guidelines, philosophies, and theories are available there but there are very limited studies in the 
implementation of diabetes care using this philosophy fully.  The association between patient 
empowerment and HbA1c is of great interest, but still not completely understood. Therefore, this 
study was focused on assessing this association.  
 
The Descriptive Analyses 
 The descriptive analyses helped to understand the characteristic of the study sample. More 
than half of the study sample was female and less than 20% were married. Less than 10% had full-
time employment and more than half of them were living with an annual income less than $10, 000. 
The mean age of the study sample was about 56 years and over half of them had an education level 
of high school graduate or GED or greater. The mean duration with diabetes was about 11 years and 
about 96% were on insulin implying that the study population was probably very familiar with 
diabetes self-management education and the health care providers of the Diabetes Clinic.  
 Cross-sectional analysis showed there were no significant differences of HbA1c level 
between the intervention groups (control/ intervention) at both intervention periods. HbA1c level was 
found to be highest in the youngest age group, was ≤ 50 years,  at baseline and at the 12 month  
period.   
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 Empowerment level of patients was measured by two scales: the DES-SF and PAM. The 
baseline mean DES score was 4.2 indicating  the empowerment level of the study sample was already 
high when compared to the mean  DES score (3.89) of urban African Americans in the City of 
Detroit (Anderson et al., 2005). The baseline mean PAM score was 74.3 indicating that the study 
sample was already in the activation level stage 4, the highest level of activation. The mean PAM 
score in this study was higher than the mean PAM score of chronic disease patients from a study in 
Oregon where the study sample was predominantly white female and between 50-70 years of age 
(Hibbard et al., 2007).  
 The descriptive cross-sectional study of DES scores (Table 3b) showed that the mean DES 
score was significantly higher in the intervention group for the less than 50 age group. It was 
significantly higher in 51-64 age group versus 65 or older age group in the control group at the 
baseline. It was also significantly higher in the study sample for subjects of more than $10,000 
annual income versus subjects with an income $5,000 to $9,999 in both treatment groups at the 
baseline (Table 3d). In addition , the mean DES score was significantly higher in the subjects with 
some college or technical school and higher level of education versus the subjects with a lower level 
of education in the intervention group at baseline (Table 3e). The findings suggest that mean DES 
scores in this sample were higher for those in the younger age group, and for those with a higher 
income level and higher education attainment. There were no significant differences of DES score 
between the intervention groups at both intervention periods. No significant differences were found 
in the cross-sectional study of PAM scores at different age, gender, income, and educational 
attainment levels.   
 
 
 
46 
 
 
Testing of Hypothesis I 
 It was hypothesized that the DES scores of patients in diabetes care would be negatively 
associated with the HbA1c level. There were some significant negative associations between DES 
scores and HbA1c level as follows: 
 overall intervention group at the 6 month period of intervention (Table 5a, p. 39), 
 the intervention group age more than or equal to 65 at the 6 month period of intervention 
(Table 5b, p. 39), 
 the intervention group female  at the 6 month period of intervention (Table 5c, p. 39), 
 the control group income $5000 to $9,999 at the 12 month period of intervention (Table 
5d, p. 40), 
 the control group who had some college or technical school or higher level of educational 
attainment at the 6 month period of intervention (Table 5e, p. 40) and 
 the intervention group who were high school graduate or GED at the 6 month period of 
intervention (Table 5e, p. 40).  
 There were also many weak negative associations between DES score and HbA1c level 
(Table 5a to 5e, p. 39 - 40). However, there was no consistent pattern of association which can 
strongly support the hypothesis. Therefore, it was concluded that there was no significant association 
between DES score and HbA1c level based on data from the sample. 
 Few studies were found that allowed for comparison of the findings from this study.. In a 
previous study which used the 37-item DES, it was concluded that patient empowerment is effective 
for both psychosocial and blood glucose level improvement (Anderson et al., 1995). The participants 
were middle-aged women, overweight and more than half were using insulin. Another study which 
used the 28-item DES-SF did not show any significant results (Anderson, et al., 2005). The study 
sample was African American and predominantly female but only 38% were on insulin. Another 
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study showed DES-SF score and HbA1c levels both changed in a positive direction, but were not 
correlated (Anderson et al., 2003).  
 
Testing of Hypothesis II 
 It was hypothesized that PAM scores of patients in diabetes care would be negatively 
associated with the HbA1c level. There were very few significant associations between PAM score 
and HbA1c level as follows: 
 the intervention group at the 6 month intervention period of the study group ≤ 50 years of age 
(Table 6b, p.41) and 
 the intervention group at the 12 month intervention period of the study group lower than high 
school graduate level of educational attainment (Table 6e, p.42). 
 There were many weak associations between PAM score and HbA1c level but there was no 
consistent pattern which can strongly support the hypothesis (Table 6a to 6e, p.41 - 42). Therefore, it 
was concluded that there was no significant association between PAM score and HbA1c level based 
on data from the sample. 
 Very few studies were found that allowed for comparison of these results. In a previous study 
which was done in the GHS, it was found that diabetes patients with high PAM score were more 
likely to engage in self-care behavior like feet checks, and exercising regularly, and they were more 
likely to receive eye examinations. However, it was not associated with HbA1c knowledge. The 
study participants were African American women with a mean age of 51 years (Rask et al., 2009). In 
another study which was done with 50-70 year old predominantly white women who were chronic 
disease patients, it was found that a positive change in PAM score was related to positive change in a 
variety of self-management behavior and also related to maintenance of that self-management 
behavior overtime (Hibbard et al., 2007). Another study by Mosen et al. (2007) which was done on 
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chronic disease patients also showed similar results, however, the study participants were about 62 
years old and predominantly white.  
 An empowerment-based multi disciplinary education program for diabetes patients with 
prolonged self-management difficulties has shown that empowerment has a beneficial effect on 
glycemic control especially in women (Keers, et al., 2006). A study of a pilot program on 
empowerment-based diabetes management among low-income African American has also shown 
better HbA1c control and higher percentage of receiveing eye, feet and dental examinations in the 
patients enrolled in the program (Greene, 2006). 
 
Limitations 
 There were many limitations to this study. This study used data of African American patients 
from the Diabetes Clinic of the Grady Health System and may not be generalizable outside this 
population. Another limitation relates to sample size. Many issues contributed to the sample size 
issue such as failure to return, failure to obtain lab work and poor adherence. Given these issues, only 
data collection at baseline through 12 month of the intervention was used for this analysis. Sample 
sizes were different between baseline and the 12 month period, and also between different 
intervention groups and among gender and different levels of age, income, and educational 
attainment. Therefore, comparison of these data was difficult. In addition, the scales used in the 
patient empowerment surveys may be less sensitive in certain populations (Bernal, Wooley, & 
Schensul, 1997; Chachamovich, Fleck, & Power, 2009; Hartley & MacLean, 2006).  
 Moreover, there were very few significant differences in the HbA1c level, DES score, and 
PAM score between the treatment groups at baseline and 12 month in this particular study sample.  
Less variation in data may be due to the fact that patients from both treatment groups were both able 
to access the endocrinologists, nutritionists, HbA1c information and standardized diabetes 
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educations. In addition, duration of diabetes for the subjects was substantial and most were on 
insulin. It is possible that the study sample was very familiar with diabetes self-management 
education and the health care providers of the Diabetes Clinic. Volunteer bias and spillover effect 
were also possible in the PEIDiC study. Finally, baseline DES score and PAM score showed their 
level of empowerment was already high. 
 
Conclusion 
 Patient empowerment scores measured by DES-SF and PAM were not significantly 
associated with HbA1c level in African American diabetes patients of the Diabetes Clinic of the 
Grady Health System. Further study is necessary to understand the association between patient 
empowerment and diabetes disease management by using different measures of patient 
empowerment, different levels of disease management, and measurement in different settings.  
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APPENDICES 
APPENDIX A: Empowered Caring Model 
 
 
 
 
Source: Falk-Rafael, A. R. (2001). Empowerment as a process of evolving consciousness: a model 
of empowered caring. Advances in Nursing Science, 24(1), pp. 5. Reproduced with permission of the 
author.
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APPENDIX B: A Real Time Road Map 
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APPENDIX C: Communication Card  
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APPENDIX D: Diabetes Empowerment Scale-Short Form 
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Appendix E: Patient Activation Measure 
